Literature DB >> 14983478

PACAP mRNA is expressed in rat spinal cord neurons.

Lina M E Pettersson1, Tony Heine, Valerie M K Verge, Frank Sundler, Nils Danielsen.   

Abstract

This study examines the expression of pituitary adenylate cyclase activating polypeptide (PACAP) mRNA in the rat spinal cord during normal conditions and in response to sciatic nerve transection. Previously, PACAP immunoreactivity has been found in fibers in the spinal cord dorsal horn and around the central canal and in neurons in the intermediolateral column (IML). Furthermore, in the dorsal root ganglia, PACAP immunoreactivity and PACAP mRNA expression have been observed preferentially in nerve cell bodies of smaller diameter terminating in the superficial laminae of the dorsal horn. However, neuronal expression of PACAP mRNA in adult rat spinal cord appeared limited to neurons of the IML. By using a refined in situ hybridization protocol, we now detect PACAP mRNA expression in neurons primarily in laminae I and II, but also in deeper laminae of the spinal cord dorsal horn and around the central canal. In addition, PACAP mRNA expression is observed in a few neurons in the ventral horn. PACAP expression in the ventral horn is increased in a population of large neurons, most likely motor neurons, both after distal and proximal sciatic nerve transection. The proposed role of PACAP in nociception is strengthened by our findings of PACAP mRNA-expressing neurons in the superficial laminae of the dorsal horn. Furthermore, increased expression of PACAP in ventral horn neurons, in response to nerve transection, suggests a role for PACAP in repair/regeneration of motor neurons. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983478     DOI: 10.1002/cne.20015

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  15 in total

1.  PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis.

Authors:  Christina Van; Michael C Condro; Kenny Lov; Ruoyan Zhu; Patrick T Ricaflanca; Henly H Ko; Anna L Diep; Anh Q Hoang; Joseph Pisegna; Hermann Rohrer; James A Waschek
Journal:  J Mol Neurosci       Date:  2018-07-30       Impact factor: 3.444

2.  Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury.

Authors:  Daisuke Tsuchikawa; Tomoya Nakamachi; Masashi Tsuchida; Yoshihiro Wada; Motohide Hori; Jozsef Farkas; Akira Yoshikawa; Nobuyuki Kagami; Nori Imai; Norihito Shintani; Hitoshi Hashimoto; Takashi Atsumi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-07       Impact factor: 3.444

3.  High-resolution characterization of a PACAP-EGFP transgenic mouse model for mapping PACAP-expressing neurons.

Authors:  Michael C Condro; Anna Matynia; Nicholas N Foster; Yukio Ago; Abha K Rajbhandari; Christina Van; Bhavaani Jayaram; Sachin Parikh; Anna L Diep; Eileen Nguyen; Victor May; Hong-Wei Dong; James A Waschek
Journal:  J Comp Neurol       Date:  2016-06-03       Impact factor: 3.215

4.  Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: implication for the sensory and behavioral effects of pain.

Authors:  Galen Missig; Carolyn W Roman; Margaret A Vizzard; Karen M Braas; Sayamwong E Hammack; Victor May
Journal:  Neuropharmacology       Date:  2014-07-03       Impact factor: 5.250

5.  PACAP causes PAC1/VPAC2 receptor mediated hypertension and sympathoexcitation in normal and hypertensive rats.

Authors:  M M J Farnham; M S Y Lung; V J Tallapragada; P M Pilowsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

6.  Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury.

Authors:  Alma Sanchez; Maurizo Chiriva-Internati; Paula Grammas
Journal:  Neurosci Lett       Date:  2008-10-14       Impact factor: 3.046

7.  Regulation of neuronal pituitary adenylate cyclase-activating polypeptide expression during culture of guinea-pig cardiac ganglia.

Authors:  B M Girard; B A Young; T R Buttolph; S L White; R L Parsons
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

8.  PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Cornelia Ringer; Luisa-Sybille Büning; Martin K H Schäfer; Lee E Eiden; Eberhard Weihe; Burkhard Schütz
Journal:  Neurobiol Dis       Date:  2013-03-04       Impact factor: 5.996

9.  VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.

Authors:  Yossan-Var Tan; Catalina Abad; Yuqi Wang; Robert Lopez; James Waschek
Journal:  Brain Behav Immun       Date:  2014-10-13       Impact factor: 7.217

Review 10.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.